Department of Medical Oncology;
Fudan University Shanghai Cancer Center;
Shanghai 200032;
China;
Department of Oncology;
Shanghai Medical College;
Fudan University;
Shanghai 200032;
China;
Immune checkpoint inhibitor therapy; prediction of efficacy; tumor mutation burden; mismatch repair deficiency; DNA damage response genes;